EUPRAXIA PHARMACEUTICALS INC.
Ownership & governance
Executives 5Directors 7Avg age 59Avg tenure 6.4y
JH
James Helliwell
Chief Executive Officer
Since 2012-07-22Profile →
+11
Executives5
Board of directors7
SP
Simon Pimstone→
Chairman
Age 58Since 2013-01-13
JH
James Helliwell→
Director/Board Member
—Since 2012-07-22
JM
John Montalbano→
Director/Board Member
Age 61Since 2013-01-13
RG
Richard Glickman→
Director/Board Member
Age 68Since 2021-03-08
JF
Joe Freedman→
Director/Board Member
—Since 2024-10-30
AP
Amy Pott→
Director/Board Member
Age 49Since 2026-06-17
RB
Robert Bazemore→
Director/Board Member
Age 58Since 2026-06-17
Shareholders5
| Name | Stake | Shares |
|---|---|---|
| Beutel, Goodman & Co. Ltd. | 6.599 % | 4,058,899 |
| Manchester Management Co. LLC | 6.529 % | 4,015,248 |
| Beutel, Goodman & Co. Ltd. | 5.961 % | 3,666,465 |
| Bob Disbrow | 5.476 % | 3,368,150 |
| Joe Freedman | 4.135 % | 2,542,933 |
Catalog · 2026-07-09
Registry officers12
| Name | Role | Since | Shares |
|---|---|---|---|
| Alex Rothwell | Director of Finance/CFO | 2025-02-17 | - |
| Alex Therien | Chief Tech/Sci/R&D Officer | 2025-10-31 | - |
| Amanda Malone | Chief Operating Officer | 2012-07-31 | - |
| James Helliwell | Chief Executive Officer | 2012-07-22 | - |
| Jeymi Tambiah | Chief Tech/Sci/R&D Officer | 2026-04-30 | - |
| Simon Pimstone | Chairman | 2013-01-13 | - |
| Amy Pott | Director/Board Member | 2026-06-17 | - |
| James Helliwell | Director/Board Member | 2012-07-22 | - |
Registry · as of 2026-07-09
Institutional (13F)
Loading Form 13F holders…
Fund membership
Loading fund baskets…
Street consensus
Consensus strong buyMean target 16.35Range 11–25Analysts 10
11Mean 16.3525
- Buy 12
Broker actions14
| Firm | Action | To | Target | Date |
|---|---|---|---|---|
| HC Wainwright & Co. | Reiterated | Buy | 11 | 2026-10-01 |
| Wedbush | Initiated | Outperform | 17 | 2026-09-24 |
| Oppenheimer | Initiated | Outperform | 17 | 2026-06-26 |
| Stifel | Initiated | Buy | 25 | 2026-05-21 |
| HC Wainwright & Co. | Reiterated | Buy | 11 | 2026-05-04 |
| HC Wainwright & Co. | Reiterated | Buy | 11 | 2026-04-22 |
| William Blair | Initiated | Outperform | — | 2026-03-23 |
| HC Wainwright & Co. | Maintained | Buy | 11 | 2026-03-17 |
| Cantor Fitzgerald | Maintained | Overweight | 19 | 2026-01-15 |
| HC Wainwright & Co. | Reiterated | Buy | 12 | 2026-01-09 |
| HC Wainwright & Co. | Reiterated | Buy | 12 | 2025-08-20 |
| Cantor Fitzgerald | Initiated | Overweight | 11 | 2025-07-24 |
Firm rows and rating mix from Yahoo Finance; mean target is Yahoo’s aggregate until OpenFilings derives consensus from broker rows.